The Global External Beam Radiation Therapy (EBRT) for Lung Cancer Market was valued at USD 6.9 billion in 2023 and is projected to reach a market size of USD 9.71 billion by 2030. Over the forecast period of 2024-2030, market is projected to grow at a CAGR of 5%.
High-energy radiation is used in External Beam Radiation Therapy (EBRT) to target and kill lung cancer cells. These beams are directed from outside the body via a device known as a linear accelerator. EBRT can be palliative, meaning it aims to reduce symptoms like pain or dyspnea, or curative, meaning it seeks a full recovery. It can be used either on its own or in conjunction with other medical therapies like chemotherapy or surgery.
Key Market Insights:
The burden of lung cancer worldwide is expected to increase because of things like smoking and air pollution. With a projected 2.2 million deaths from lung cancer in 2020, lung cancer is the largest cause of cancer-related deaths globally.
There is a boom in innovation in the EBRT sector. Radiation therapy methods such as stereotactic radiosurgery (SRS) provide extremely accurate radiation with few side effects. SRS was able to produce an 86.2% 5-year local control rate for patients with early-stage lung cancer. When combined with fewer side effects, this increase in therapeutic efficacy is encouraging patient uptake and propelling market expansion.
Access to EBRT is expected to increase as developing nations' healthcare infrastructure gets stronger. From 2022 to2028, the Asia Pacific EBRT market for lung cancer is expected to expand at a noteworthy CAGR of 8.2.
EBRT is frequently combined with other therapies for lung cancer. Improvements in immunotherapy and targeted medicines are opening new possibilities for more potent combinations. In comparison to EBRT alone, patients with lung cancer who received immunotherapy in addition to EBRT had a considerably higher progression-free survival rate, according to a 2023 clinical study that was published in Nature Medicine. As these therapeutic approaches become more commonly used, the market for EBRT might be greatly boosted by the possibility for improved patient outcomes through combination therapy.
Global External Beam Radiation Therapy (EBRT) for Lung Cancer Market Drivers:
Increasing Rates of Lung Cancer: A Double-edged Sword for the EBRT Industry
The EBRT market is shadowed by the increased prevalence of lung cancer, yet this shadow fosters growth. The main cause of this increase is the persistence of smoking, which is a known risk factor for lung cancer. But there are other variables at play than personal preferences. One major factor is air pollution, especially in emerging nations with high levels of traffic and increasing industries. The prognosis for lung cancer diagnosis is alarming due to these variables combined. This sobering fact serves as EBRT's main market motivator. The need for efficient treatment alternatives like EBRT will increase in tandem with the growth in lung cancer occurrences. EBRT is an essential component in the management of this expanding public health issue as it provides a useful weapon in the battle against lung cancer. The market will advance as more people are diagnosed with lung cancer, which will result in a greater pool of candidates for EBRT.
Redefining Treatment Accuracy, Reducing Adverse Effects, and Increasing Patient Acceptability for Industry Development
Revolutionary developments in radiation treatment methods are driving a revival in the EBRT business. The days of wide, inaccurate radiation beams are long gone. These days, a paradigm change is possible because to cutting-edge technology like intensity-modulated radiation treatment (IMRT) and stereotactic radiosurgery (SRS). By using these procedures, radiation doses are delivered with extreme precision, minimising harm to nearby healthy tissues. Patients benefit from both better treatment outcomes and far fewer side effects because of this. Better tumour control and improved quality of life both during and after therapy are now possible for patients. With its increased tolerability, EBRT becomes a more appealing choice for a larger group of patients, which will eventually spur market uptake and advance the treatment's future.
Global External Beam Radiation Therapy (EBRT) for Lung Cancer Market Restraints and Challenges:
Despite its value, the worldwide market for EBRT for lung cancer is not without obstacles. Access may be hampered by the high cost of care and equipment, especially in areas with underdeveloped healthcare systems. Side effects like exhaustion and skin irritation can also discourage patients or make more supportive care necessary, which raises the expense of treatment even more. A competitive challenge arises from the development of alternative therapies, such as tailored drugs and minimally invasive surgery, which may provide better results or fewer side effects for some individuals. Furthermore, the availability of EBRT may be limited in some places because to a lack of qualified radiation oncologists and technicians. Finally, poor reimbursement practices for healthcare might put a financial strain on both patients and providers, which would impede the expansion of the market. These elements work together to generate obstacles that the market for EBRT for lung cancer must get beyond.
Global External Beam Radiation Therapy (EBRT) for Lung Cancer Market Opportunities:
Though there are still obstacles to overcome, the global EBRT for lung cancer market offers intriguing prospects. The growing number of lung cancer cases brought on by smoking and pollution will increase the demand for efficient therapies like EBRT. Improvements in patient outcomes and treatment uptake can be attributed to technological innovations like as intensity-modulated radiation therapy and stereotactic radiosurgery, which provide more accurate radiation with less side effects. Furthermore, there is a huge prospective market for EBRT access due to the expansion of developing nations with better healthcare facilities. Furthermore, as these complementary therapies progress, EBRT's function in combination therapies with immunotherapy and targeted medicines may be strengthened. By concentrating on early lung cancer identification, EBRT can be applied more successfully, thereby increasing the number of eligible patients. In the upcoming years, the worldwide market for EBRT for lung cancer might be greatly boosted by these variables together.
EXTERNAL BEAM RADIATION THERAPY (EBRT) FOR LUNG CANCER MARKET REPORT COVERAGE:
|
REPORT METRIC |
DETAILS |
|
Market Size Available |
2023 - 2030 |
|
Base Year |
2023 |
|
Forecast Period |
2024 - 2030 |
|
CAGR |
5% |
|
Segments Covered |
By Technology, Application, End-User, and Region |
|
Various Analyses Covered |
Global, Regional & Country Level Analysis, Segment-Level Analysis, DROC, PESTLE Analysis, Porter’s Five Forces Analysis, Competitive Landscape, Analyst Overview on Investment Opportunities |
|
Regional Scope |
North America, Europe, APAC, Latin America, Middle East & Africa |
|
Key Companies Profiled |
Accuray Incorporated (US) , Elekta AB (Sweden) , IBA (Belgium) , Siemens Healthineers GmbH (Germany) ,ViewRay Technologies, Inc. (US) |
Conventional EBRT
Advanced EBRT
It is anticipated that the market for EBRT for lung cancer would significantly change, with Advanced EBRT emerging as the leading and fastest-growing sector. Although traditional EBRT methods, such as 3D-CRT, have been used in the past, their ability to produce wider radiation fields may increase adverse effects. Conversely, Advanced EBRT presents a novel strategy utilising methods such as Intensity-Modulated Radiation Therapy (IMRT) and Stereotactic Radiosurgery (SRS). By delivering precisely tailored radiation doses, these approaches dramatically improve patient outcomes and treatment acceptability while minimising harm to healthy tissues. Advanced EBRT is rapidly gaining traction because to its emphasis on accuracy and fewer side effects, positioning it as the industry leader in the rapidly changing EBRT environment for the treatment of lung cancer.
Curative Treatment
Palliative Treatment
The increasing incidence of lung cancer cases, particularly with early identification when curative treatments are more advantageous, probably accounts for the increased market share held by curative treatment. The significance of curative EBRT may be cemented by early identification initiatives and EBRT technological developments that increase efficacy. Although it may be influenced by the total number of cases of lung cancer, palliative care may not expand as quickly as curative treatments. Reduced need for palliative care due to late-stage diagnoses might result from advancements in early diagnosis and treatment options. Although identifying the fastest-growing category is difficult, curative EBRT appears to have a good chance of doing so given its emphasis on increasing cure rates and possibility for early identification.
Hospitals
Ambulatory Surgical Centers
Cancer Treatment Centers
Because of their extensive infrastructure and resources for healthcare, hospitals now hold a significant market share in the EBRT for lung cancer industry. They have the trained medical personnel, such as radiation oncologists and technicians, to operate the sophisticated EBRT equipment, and they also store it. On the other hand, the fastest-growing markets are expected to be cancer treatment facilities and ambulatory surgery centres. Because ambulatory surgical centres have reduced operating expenses, they are more often doing EBRT operations, especially for less difficult cases.
North America
Asia-Pacific
Europe
South America
Middle East and Africa
Even though North America dominates the market now, there will soon be a shift in geography for EBRT for lung cancer. Due to three factors, the Asia-Pacific region is predicted to grow at the fastest rate: an ageing population that is more susceptible to lung cancer; rising lung cancer rates that follow the global trend; and developing economies with improved healthcare infrastructure that spur access to EBRT. In the years to come, this combination of factors is probably going to push the Asia-Pacific area to the top of the lung cancer EBRT market.
COVID-19 Impact Analysis on the Global External Beam Radiation Therapy (EBRT) for Lung Cancer Market:
The COVID-19 epidemic has had a mixed effect on the market for EBRT for lung cancer. Healthcare system disruptions probably delayed the diagnosis of lung cancer and the start of EBRT, which might have a negative impact on patient outcomes and narrow the pool of patients who are eligible in the short term. Furthermore, EBRT capability may be restricted owing to overstretched resources because of COVID-19 situations. Anxieties among patients over the virus may have contributed to treatment avoidance or delays in hospitals. But the epidemic also brought with it unanticipated possibilities. Remote patient monitoring and EBRT consultations are now more accessible thanks to the growth of telehealth consultations. Following the pandemic, there may be a greater emphasis on early diagnosis, which might lead to the identification of more people as good candidates for EBRT at an earlier, more manageable stage. Moreover, it's possible that the pandemic unintentionally hastened the creation and use of new technology enabling quicker and more affordable EBRT treatment. In conclusion, even if the pandemic created some short-term difficulties, there may be a combination of long-term improvements and setbacks for the market for EBRT for lung cancer.
Recent Trends and Developments in the Global External Beam Radiation Therapy (EBRT) for Lung Cancer Market:
The market for EBRT for lung cancer is dynamically changing on a worldwide scale. Modern methods that reduce side effects and improve accuracy, including as image-guided treatment and stereotactic radiosurgery, are making EBRT a more appealing alternative for a larger group of patients. Additionally, the industry is embracing less intrusive methods and investigating extremely successful pairings between immunotherapy and targeted medicines. Additionally, developments in telehealth are making consultations and remote monitoring more accessible, and the expansion of developing countries is opening fascinating new markets. EBRT is positioned as a potent weapon in the ongoing fight against lung cancer because of its emphasis on innovation and better patient experiences.
Key Players:
Accuray Incorporated (US)
Elekta AB (Sweden)
IBA (Belgium)
Siemens Healthineers GmbH (Germany)
ViewRay Technologies, Inc. (US)
Global automotive lighting refers to all vehicle lighting systems, from headlamps that illuminate the road to taillights that communicate movements. They guarantee motorists and other road users alike safety, visibility, and style. While taillights frequently use LEDs for improved visibility, headlights are available in a variety of technologies, including LED and laser. Interior illumination, DRLs, and signal lights all have a role to play. This market, which was estimated to be worth $33.64 billion in 2022, is anticipated to rise to $67.39 billion by 2030 because of laws, luxury tastes, safety concerns, and technological developments like OLED taillights and adaptive headlights. Anticipate a future dominated by intelligent, connected, personalized, and sustainable lighting systems that enhance the safety, efficiency, and aesthetic appeal of automobiles.
Car lighting works its magic to provide safety, visibility, and style. Headlights cut through the night, taillights express intent, and interiors shine with comfort. The billion-dollar global business is expected to rise due to consumer demand for high-end experiences, safer roads, and cutting-edge technology. Imagine dynamic messages being painted by taillights, headlights that adjust to the road, and interiors that customize their atmosphere. Driven by technological advancements like linked systems and laser beams, this future is calling. Anticipate even more visually attractive, environmentally friendly, and intelligent lighting to illuminate the way ahead, making cars safer, more efficient, and unquestionably cooler.
In the market for automobile lighting, safety is the driving force behind demand from the public and laws. While automated high beams smoothly react to traffic, adaptive headlights modify their beams so as not to blind other people. With visually striking displays, dynamic taillights convey intentions for braking and turning. Beyond these developments, integrated pedestrian identification and lane departure alerts will soon make roads safer and brighter for everyone.
Luxurious automobile lighting creates a distinct visual identity that goes beyond simple illumination. Personalized interior lighting customizes the driving experience by setting the mood with a range of colours and intensities, while intricate designs and distinctive DRLs modify exteriors. As you approach your automobile at night, welcoming lights lead the way, resulting in an interior that is perfectly lit. Not only is this symphony of light aesthetically pleasing, but it also stands as a tribute to luxury. Upcoming developments like gesture-controlled lighting and holographic displays promise to further enhance the experience.
The worldwide automotive lighting market is undergoing a significant transition towards energy-efficient solutions, as environmental concerns gain prominence. LED technology is leading the way, providing a ray of hope for the environment and drivers alike. LED lights beam brighter and use a lot less energy than conventional halogen lamps. There are some tangible advantages to this. For drivers, this translates to increased fuel economy, which lowers petrol prices and lessens reliance on fossil fuels. Greater air quality and a reduction in the transport sector's contribution to climate change are the results of reduced overall emissions.
Although the global automotive lighting business is booming, there are still unknowns. Difficulties impede growth even as innovation propels it with eye catching features like laser beams and adaptable headlights. These technologies are luxury items due to their high cost and difficult integration, which puts producers' abilities to the test. The worldwide patchwork created by unclear legislation limits the potential of innovation. Durability issues persist, particularly when complex systems are subjected to challenging conditions. Ultimately, a lot of drivers still don't fully understand how these improvements can help them. Together, we can overcome these obstacles. The keys to reducing costs are improved production, more seamless integration, and unified regulations. Their full potential can be realized by educating customers about the safety, efficiency, and aesthetic value of these lighting wonders. By working together, we can pave the way for an even brighter and safer future for vehicle lighting.
It is made possible by advanced LED technology, which gives drivers the ability to customize their illumination for the highest level of comfort and flair. Consumers that care about the environment want greener products, and vehicle lighting complies. While solar- and self-powered lighting technologies offer a future powered by clean energy, energy-efficient LEDs lower pollution. The advent of connected lighting systems heralds a new age. Envision automobiles interacting with infrastructure and one another to minimize accidents and enhance traffic efficiency. Integrated headlights with pedestrian recognition provide unmatched safety, while dramatic taillights with eye-catching displays alert onlookers to your intentions. The possibilities are endless in the future. Gesture-controlled interior illumination, holographic displays projected onto the road, and even light fixtures with self-healing capabilities.
Due to laws requiring safety features like headlights, taillights, and brake lights, exterior lighting presently holds the most market share in the vehicle lighting industry. The dominance of this market is partly attributed to advancements in safety-focused technologies such as adaptive headlights and daytime running lights. The market value of external lighting is increased by the quick adoption of technology like LED bulbs and laser lights, which improve performance and aesthetics. Conversely, the interior lighting market is expected to increase at the fastest rate in the upcoming years. Innovations like ambient lighting and technology breakthroughs like LED and OLED displays, driven by consumer demand for comfort and personalisation, open new possibilities. The spread of sophisticated interior lighting systems is further driven by the growing emphasis on safety and the expansion of the luxury car market.
The worldwide vehicle lighting market is currently dominated by halogen because of its more affordable price, advanced technology, and useful illumination. With its dependable supply chain and affordable option for manufacturers and cost-conscious customers, halogen holds the biggest market share. The fastest-growing market right now is LEDs, which are predicted to shortly overtake halogen. The rapid expansion of LEDs is driven by their higher efficiency, longer lifespan, flexibility in design, and technological breakthroughs including enhanced brightness. Because LEDs use less energy and produce fewer emissions and better fuel economy, they are becoming more and more popular in the changing automotive lighting market.
Passenger automobiles rule the worldwide automotive lighting market. The sheer number of passenger cars produced which surpasses that of business vehicles and fuels the need for lighting systems is the primary cause of this popularity. The growing demand for personal automobiles in developing nations is a result of rising disposable income, which in turn drives the rise of the passenger car market. The importance that consumers place on safety and aesthetics elements helps to drive market expansion. But in the upcoming years, the market for electric and hybrid cars is expected to develop at the quickest rate. The exponential rise of the worldwide electric car market, which is still expanding and shows no signs of slowing down, is what is driving this surge. Specialised lighting solutions are required since electric and hybrid vehicles have different lighting requirements because of their specific functionality and design aesthetics.
Most lighting systems sold nowadays are sold by OEMs (Original Equipment Manufacturers), primarily because manufacturers pre-install lighting systems in new cars. But in the next years, the aftermarket is expected to develop at the quickest rate. This spike in demand for replacement parts, especially lighting systems, can be linked to several variables, one of them being the average age of cars. The industry is expanding because of consumers' growing desire to personalise their cars with aftermarket lighting upgrades such LED upgrades and decorative lighting. The availability and affordability of technologies like adaptive headlights and laser lights in the aftermarket, together with other advancements in lighting technology, are driving demand even more. Moreover, the growing market for electric cars (EVs).
Throughout the forecast period, Asia Pacific is anticipated to be the automotive lighting market with the highest profitability. Over the past few years, Asia Pacific countries like China and India have seen notable increases in automotive manufacturing and sales, primarily in the medium-to premium luxury car segment. Asia Pacific is predicted to see an increase in the manufacturing of passenger cars, with India experiencing the strongest growth rate. Depending on the state of the national economy, the area offers a suitable selection of both high-end and cheap cars. For instance, there is a substantial demand for halogen, Xenon/HID, and LED since China and India produce more economy and mid-range automobiles. On the other hand, luxury car adoption rates are greater in South Korea and Japan, where LED lighting is the norm.
A brief shadow was thrown by COVID-19 over the worldwide automotive lighting market. Production was stopped by lockdowns and supply chain disruptions, while luxury lighting upgrades were shelved by consumers on a tight budget. Resources became scarce, and R&D stagnated. Still, the market is recovering thanks to resurgent demand and rearranged priorities. While energy-efficient LEDs are being pushed towards adoption by sustainability, safety concerns are driving interest in features like pedestrian detection and adaptive headlights. The digital push of the epidemic creates opportunities for intelligent, networked lighting systems that may interact with infrastructure and other cars. Ultimately, the industry is positioned to shine brighter, focused on safety, sustainability, and a connected future, even though the pandemic dimmed its brilliance.
A development collaboration between OSRAM Continental and REHAU aims to incorporate lighting into external components, providing automobile manufacturers with innovative lighting options that improve functionality and design flexibility. For rear combination lamps, Hella unveiled a revolutionary lighting innovation called Hella FlatLight technology. A Memorandum of Understanding (MoU) was signed by Samvardhana Motherson Automotive Systems Group BV (SMRPBV), a division of Motherson Group, and Marelli Automotive Lighting to investigate a technology collaboration focused on intelligently lighted external body components. Valeo debuted their revolutionary 360° lighting system at the Shanghai Auto Show. This technology surrounds the car with a band of light, projecting instantaneous, clear signs that other drivers can see from a distance. Pedestrians, cyclists, and scooter riders are especially susceptible to these signals
The Global External Beam Radiation Therapy (EBRT) for Lung Cancer Market size is valued at USD 6.9 billion in 2023.
The worldwide Global External Beam Radiation Therapy (EBRT) for Lung Cancer Market growth is estimated to be 5% from 2024 to 2030.
The Global External Beam Radiation Therapy (EBRT) for Lung Cancer Market is segmented By Technology (Conventional EBRT, Advanced EBRT); By Application (Curative Treatment, Palliative Treatment); By End-User (Hospitals, Ambulatory Surgical Centres, Cancer Treatment centres) and by region.
Because of ongoing developments in fields like less invasive procedures and accurate radiation technology, the market for EBRT for lung cancer appears to have a bright future. Furthermore, the development of immunotherapy and targeted medicines in conjunction with EBRT offers promising opportunities to enhance patient outcomes. Additionally, the expansion of emerging economies opens new markets, maybe with an emphasis on affordable EBRT solutions.
There was a mixed effect of the COVID-19 epidemic on the market for EBRT for lung cancer. In the short run, it resulted in treatment delays and could have shrunk the patient pool, but in the long run, it might have spurred a fresh emphasis on early identification, which might help the market.
Joining thousands of companies around the world committed to making the Excellent Business Solutions.
Specify your preferred Countries, Segments, or timeframes
Unlock Country Level Outlook, Trends, Cross-country Comparability, or supply Chain Variations.
Analyst Support
Every order comes with Analyst Support.
Customization
We offer customization to cater your needs to fullest.
Verified Analysis
We value integrity, quality and authenticity the most.
 FOR LUNG CANCER MARKET .png)
